APC 366-A: Began a U.S. Phase I trial

Arris Pharmaceutical Corp. (ARRS), South San Francisco Product: APC 366-A small molecule inhibitor of mast cell tryptase enzyme, a regulator of the inflammatory cascade Indication: Asthma Status: Beg...